Abbott Laboratories (ABT) – Innovation as driver for growth
in Healthcare & Life Sciences , Medical Devices & Equipments on April 18, 2022ABT adopts the strategy of innovation to improve its product portfolio which can contribute towards the long term growth. In FY21, ABT continued to strengthen their Medical Device portfolio with several pipeline advancements and launches.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
Crispidea Coverage
No of Pages : 37
Recent Blog Posts
Related Products
Popular & Trending
Featured Products
